Is there a preferential approach for systemic therapy for triple negative breast cancer patients with leptomeningeal disease?  

In a patient with isolated leptomeningeal disease (no systemic disease), would you still recommend systemic therapy?



Answer from: Medical Oncologist at Academic Institution